BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33798722)

  • 1. Arsenic-induced epigenetic changes in cancer development.
    Saintilnord WN; Fondufe-Mittendorf Y
    Semin Cancer Biol; 2021 Nov; 76():195-205. PubMed ID: 33798722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic reprogramming in inorganic arsenic-mediated gene expression patterns during carcinogenesis.
    Eckstein M; Eleazer R; Rea M; Fondufe-Mittendorf Y
    Rev Environ Health; 2017 Mar; 32(1-2):93-103. PubMed ID: 27701139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenomic disruptions in arsenic-induced carcinogenesis.
    Sage AP; Minatel BC; Ng KW; Stewart GL; Dummer TJB; Lam WL; Martinez VD
    Oncotarget; 2017 Apr; 8(15):25736-25755. PubMed ID: 28179585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis.
    Islam R; Zhao L; Wang Y; Lu-Yao G; Liu LZ
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells.
    Bi Z; Zhang Q; Fu Y; Seno A; Wadgaonkar P; Qiu Y; Almutairy B; Xu L; Zhang W; Thakur C; Chen F
    Semin Cancer Biol; 2021 Nov; 76():310-318. PubMed ID: 33823236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic reprogramming in iAs-mediated carcinogenesis.
    George S; Cassidy RN; Saintilnord WN; Fondufe-Mittendorf Y
    Adv Pharmacol; 2023; 96():319-365. PubMed ID: 36858778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient and permanent changes in DNA methylation patterns in inorganic arsenic-mediated epithelial-to-mesenchymal transition.
    Eckstein M; Rea M; Fondufe-Mittendorf YN
    Toxicol Appl Pharmacol; 2017 Sep; 331():6-17. PubMed ID: 28336213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulations in alternative telomere lengthening: Understanding the mechanistic insight in arsenic-induced skin cancer patients.
    Bhattacharjee P; Das A; Giri AK; Bhattacharjee P
    Sci Total Environ; 2020 Feb; 704():135388. PubMed ID: 31837846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic targets of arsenic: emphasis on epigenetic modifications during carcinogenesis.
    Roy RV; Son YO; Pratheeshkumar P; Wang L; Hitron JA; Divya SP; D R; Kim D; Yin Y; Zhang Z; Shi X
    J Environ Pathol Toxicol Oncol; 2015; 34(1):63-84. PubMed ID: 25746832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.
    Ren X; McHale CM; Skibola CF; Smith AH; Smith MT; Zhang L
    Environ Health Perspect; 2011 Jan; 119(1):11-9. PubMed ID: 20682481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.
    Wang Z; Yang C
    Semin Cancer Biol; 2019 Aug; 57():95-104. PubMed ID: 30641125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic model of inorganic arsenic-induced carcinogenesis reveals an epigenetic mechanism for epithelial-mesenchymal plasticity.
    Rea M; Kimmerer G; Mittendorf S; Xiong X; Green M; Chandler D; Saintilnord W; Blackburn J; Gao T; Fondufe-Mittendorf YN
    Environ Pollut; 2024 Apr; 347():123586. PubMed ID: 38467368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the dynamic aberrant landscape of DNA methylation and gene expression during arsenic-induced cell transformation.
    Barajas-Olmos FM; Ortiz-Sánchez E; Imaz-Rosshandler I; Córdova-Alarcón EJ; Martínez-Tovar A; Villanueva-Toledo J; Morales-Marín ME; Cruz-Colín JL; Rangel C; Orozco L; Centeno F
    Gene; 2019 Aug; 711():143941. PubMed ID: 31242453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic and cancer: Evidence and mechanisms.
    Speer RM; Zhou X; Volk LB; Liu KJ; Hudson LG
    Adv Pharmacol; 2023; 96():151-202. PubMed ID: 36858772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation.
    Reichard JF; Puga A
    Epigenomics; 2010 Feb; 2(1):87-104. PubMed ID: 20514360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.
    Cardoso APF; Al-Eryani L; States JC
    Toxicol Sci; 2018 Oct; 165(2):284-290. PubMed ID: 29846715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alteration of mitochondrial biogenesis regulatory genes in arsenic exposed individuals (with and without skin lesions) and in skin cancer tissues: A case control study.
    Sanyal T; Paul M; Bhattacharjee S; Bhattacharjee P
    Chemosphere; 2020 Nov; 258():127305. PubMed ID: 32563914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
    Suzuki T; Nohara K
    Nihon Eiseigaku Zasshi; 2015; 70(3):181-5. PubMed ID: 26411935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis.
    van Breda SG; Claessen SM; Lo K; van Herwijnen M; Brauers KJ; Lisanti S; Theunissen DH; Jennen DG; Gaj S; de Kok TM; Kleinjans JC
    Arch Toxicol; 2015 Nov; 89(11):1959-69. PubMed ID: 25199682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.